Belgium vs South Korea: Immunization, Hib3 (% of children ages 12-23 months)
Belgium
97.0%
in 2024
South Korea
97.0%
in 2024
Belgium rank
29th
South Korea rank
29th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Belgium
- South Korea
How they compare
Belgium currently reports 97.0% against 97.0% in South Korea, a difference of 0.0%.
The two have swapped places 5 times across 11 shared years of data; in 2014 it was Belgium ahead.
Belgium ranks 29th and South Korea ranks 29th of 191 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and South Korea in 1.
Head to head by decade
| Decade | Belgium | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.3% | 97.5% | 0.2% | South Korea |
| 2020s | 97.0% | 96.6% | 0.4% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Belgium or South Korea?
- Belgium, at 97.0% against 97.0% in South Korea as of 2024.
- What is the difference in immunization, hib3 between Belgium and South Korea?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and South Korea?
- 11 years are reported by both, from 2014 to 2024.
- How do Belgium and South Korea rank globally for immunization, hib3?
- Belgium ranks 29th and South Korea ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.